tirzepatide male fertility Tirzepatide: A Game-Changer for Men With Obesity and Low Testosterone? Little Evidence That GLP-1 Agonists

Mohammada A, Mohd-Yusofa B-N, Hanipahc ZN, Mohd Redzwan S, Yusof LM, Khosroshahi MZ, et al

In 2021, semaglutide was FDA-approved for chronic weight management in those with obesity or overweight under the brand name Wegovy

The combination produces a sustained, physiologically normal pulsatile GH release pattern that builds in effect over weeks and months

Resources We Trust Mayo Clinic: Pros and Cons of GLP-1 Agonists for Weight Loss Yale Medicine: GLP-1 Weight-Loss Pills: What You Need to Know Johns Hopkins University: The Pros, Cons, and Unknowns of Popular Weight-Loss Drugs UC Davis Health: GLP-1 and Health: Beyond Weight Loss in the Ozempic Era Mount Sinai: What Are the Benefits of the New GLP-1 Weight Loss Pills